SPY404.11+4.02 1.00%
DIA324.41+1.63 0.51%
IXIC11,802.33+139.54 1.20%

--BMO Capital Adjusts Price Target on Bristol-Myers Squibb to $92 From $87, Keeps Outperform Rating

MT Newswires · 05/02/2022 04:54

Please log in to view news